• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺酶抑制剂诱导I类酶的多种潜在作用。

Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

作者信息

Weber D A, Sanders C C

机构信息

Department of Medical Microbiology, Creighton University School of Medicine, Omaha, Nebraska 68178.

出版信息

Antimicrob Agents Chemother. 1990 Jan;34(1):156-8. doi: 10.1128/AAC.34.1.156.

DOI:10.1128/AAC.34.1.156
PMID:2327752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171539/
Abstract

The ability of various beta-lactamase inhibitors to induce class I beta-lactamases was assessed. Clavulanate was the most active compound, inducing Morganella morganii, Aeromonas caviae, and Enterobacter aerogenes over a broad concentration range and Citrobacter freundii, Pseudomonas aeruginosa, and Serratia marcescens at high concentrations. Disk approximation tests paralleled these results, with clavulanate, but not sulbactam or tazobactam, antagonizing the activity of several beta-lactams against these organisms.

摘要

评估了各种β-内酰胺酶抑制剂诱导I类β-内酰胺酶的能力。克拉维酸是最具活性的化合物,在较宽的浓度范围内可诱导摩根氏摩根菌、豚鼠气单胞菌和产气肠杆菌产生β-内酰胺酶,在高浓度时可诱导弗氏柠檬酸杆菌、铜绿假单胞菌和粘质沙雷氏菌产生β-内酰胺酶。纸片扩散试验的结果与此相符,克拉维酸可拮抗几种β-内酰胺类药物对这些菌的活性,而舒巴坦或他唑巴坦则不能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0550/171539/e537e2aedf05/aac00057-0189-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0550/171539/e537e2aedf05/aac00057-0189-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0550/171539/e537e2aedf05/aac00057-0189-a.jpg

相似文献

1
Diverse potential of beta-lactamase inhibitors to induce class I enzymes.β-内酰胺酶抑制剂诱导I类酶的多种潜在作用。
Antimicrob Agents Chemother. 1990 Jan;34(1):156-8. doi: 10.1128/AAC.34.1.156.
2
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.β-内酰胺酶抑制剂对其与具有I类酶的生物体的配伍药物效力的影响。
Antimicrob Agents Chemother. 1991 Jul;35(7):1343-7. doi: 10.1128/AAC.35.7.1343.
3
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.他唑巴坦和克拉维酸与诱导型和组成型表达的I类β-内酰胺酶的相互作用。
J Antimicrob Chemother. 1990 Feb;25(2):199-208. doi: 10.1093/jac/25.2.199.
4
Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.革兰氏阴性菌的诱导型I类β-内酰胺酶与对β-内酰胺抗生素的耐药性
J Antimicrob Chemother. 1986 Jan;17(1):51-61. doi: 10.1093/jac/17.1.51.
5
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.哌拉西林-他唑巴坦与替卡西林-克拉维酸的体外活性比较
Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74. doi: 10.1128/AAC.33.8.1268.
6
Interactions of meropenem with class I chromosomal beta-lactamases.美罗培南与I类染色体β-内酰胺酶的相互作用。
J Antimicrob Chemother. 1989 Sep;24 Suppl A:207-17. doi: 10.1093/jac/24.suppl_a.207.
7
Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.β-内酰胺类与β-内酰胺酶抑制剂联合制剂:抗菌活性及酶抑制效果
Am J Health Syst Pharm. 1995 Mar 15;52(6 Suppl 2):S15-22. doi: 10.1093/ajhp/52.6_Suppl_2.S15.
8
Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.β-内酰胺酶抑制剂对染色体β-内酰胺酶的诱导/抑制作用
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S562-8. doi: 10.1093/clinids/8.supplement_5.s562.
9
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.新型β-内酰胺酶抑制剂YTR 830与不同β-内酰胺类抗生素联合应用对携带已知β-内酰胺酶细菌的比较评价。
Antimicrob Agents Chemother. 1986 May;29(5):955-7. doi: 10.1128/AAC.29.5.955.
10
Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.使用含和不含β-内酰胺酶抑制剂的微量稀释板作为大肠杆菌、克雷伯菌属、肠杆菌属、弗氏柠檬酸杆菌和粘质沙雷氏菌中β-内酰胺酶产生的表型检测方法。
Antimicrob Agents Chemother. 1999 Jun;43(6):1393-400. doi: 10.1128/AAC.43.6.1393.

引用本文的文献

1
Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales.产AmpC肠杆菌科细菌所致感染的抗生素治疗
Pharmacy (Basel). 2024 Sep 21;12(5):142. doi: 10.3390/pharmacy12050142.
2
Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study.碳青霉烯类与非碳青霉烯类方案治疗产AmpCβ-内酰胺酶肠杆菌科细菌血症患者的临床结局:一项单中心研究
Antibiotics (Basel). 2024 Jul 29;13(8):709. doi: 10.3390/antibiotics13080709.
3
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.

本文引用的文献

1
In vitro antagonism of beta-lactam antibiotics by cefoxitin.头孢西丁对β-内酰胺类抗生素的体外拮抗作用。
Antimicrob Agents Chemother. 1982 Jun;21(6):968-75. doi: 10.1128/AAC.21.6.968.
2
Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.多种β-内酰胺类抗生素对阴沟肠杆菌β-内酰胺酶的诱导作用。
Antimicrob Agents Chemother. 1980 Sep;18(3):382-5. doi: 10.1128/AAC.18.3.382.
3
Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.头孢西丁对羧苄青霉素和头孢孟多在小鼠实验性感染治疗中的拮抗作用
肠杆菌科细菌哌拉西林/他唑巴坦敏感性试验的解释标准:美国抗菌药物敏感性试验委员会的建议
Clin Infect Dis. 2024 Dec 17;79(6):1354-1362. doi: 10.1093/cid/ciae328.
4
Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against .利用宿主模拟条件和小鼠皮肤脓肿模型来鉴定针对 的协同抗生素组合。
Front Cell Infect Microbiol. 2024 May 14;14:1352339. doi: 10.3389/fcimb.2024.1352339. eCollection 2024.
5
Analysis of BlaEC family class C beta-lactamase.BlaEC家族C类β-内酰胺酶分析
FEMS Microbiol Lett. 2023 Jan 17;370. doi: 10.1093/femsle/fnad097.
6
Enterobacter cloacae infection characteristics and outcomes in battlefield trauma patients.阴沟肠杆菌感染的战场创伤患者的特征和结局。
PLoS One. 2023 Aug 29;18(8):e0290735. doi: 10.1371/journal.pone.0290735. eCollection 2023.
7
Molecular Basis of AmpC β-Lactamase Induction by Avibactam in : PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants.阿维巴坦诱导 AmpCβ-内酰胺酶的分子基础:对结合蛋白的占有率、活细胞结合动力学及对携带 PDC-X 变异的耐药临床分离株的影响。
Int J Mol Sci. 2021 Mar 17;22(6):3051. doi: 10.3390/ijms22063051.
8
Synthesis, Antibacterial, and Antioxidant Evaluation of Novel Series of Condensed Thiazoloquinazoline with Pyrido, Pyrano, and Benzol Moieties as Five- and Six-Membered Heterocycle Derivatives.新型稠合噻唑并喹唑啉类化合物的合成、抗菌和抗氧化评价作为五元及六元杂环衍生物的吡啶并、吡喃并和苯并部分。
Molecules. 2021 Jan 12;26(2):357. doi: 10.3390/molecules26020357.
9
Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.诱导质粒介导的 AmpC β-内酰胺酶 DHA-1 由哌拉西林/他唑巴坦和其他β-内酰胺类药物在肠杆菌科。
PLoS One. 2019 Jul 8;14(7):e0218589. doi: 10.1371/journal.pone.0218589. eCollection 2019.
10
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.AmpC β-内酰胺酶入门:应对日益增多的多重耐药问题的必备知识
Clin Infect Dis. 2019 Sep 27;69(8):1446-1455. doi: 10.1093/cid/ciz173.
Antimicrob Agents Chemother. 1982 Jun;21(6):963-7. doi: 10.1128/AAC.21.6.963.
4
In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.β-内酰胺类抗生素组合的体外和体内抗菌作用
Antimicrob Agents Chemother. 1981 Apr;19(4):634-8. doi: 10.1128/AAC.19.4.634.
5
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.革兰氏阴性菌的I型β-内酰胺酶:与β-内酰胺类抗生素的相互作用
J Infect Dis. 1986 Nov;154(5):792-800. doi: 10.1093/infdis/154.5.792.
6
Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.对新型β-内酰胺类抗生素具有多重耐药性的染色体头孢菌素酶。
Annu Rev Microbiol. 1987;41:573-93. doi: 10.1146/annurev.mi.41.100187.003041.
7
The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.
J Antimicrob Chemother. 1988 Aug;22(2):105-11. doi: 10.1093/jac/22.2.105.
8
Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
J Antimicrob Chemother. 1988 Jan;21(1):9-16. doi: 10.1093/jac/21.1.9.
9
Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.β-内酰胺酶抑制剂对染色体β-内酰胺酶的诱导/抑制作用
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S562-8. doi: 10.1093/clinids/8.supplement_5.s562.
10
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.新型β-内酰胺酶抑制剂YTR 830与不同β-内酰胺类抗生素联合应用对携带已知β-内酰胺酶细菌的比较评价。
Antimicrob Agents Chemother. 1986 May;29(5):955-7. doi: 10.1128/AAC.29.5.955.